These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11311122)

  • 1. Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression.
    Maitra R; Halpin PA; Karlson KH; Page RL; Paik DY; Leavitt MO; Moyer BD; Stanton BA; Hamilton JW
    Biochem J; 2001 May; 355(Pt 3):617-24. PubMed ID: 11311122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
    Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
    Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
    PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitors.
    Haouala A; Rumpold H; Untergasser G; Buclin T; Ris HB; Widmer N; Decosterd LA
    Drug Metab Lett; 2010 Apr; 4(2):114-9. PubMed ID: 20446917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein.
    Narayanan G; Merrill D; An R; Nolte DD; Turek JJ
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1154-1159. PubMed ID: 31103263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.
    Fardel O; Lecureur V; Daval S; Corlu A; Guillouzo A
    Eur J Biochem; 1997 May; 246(1):186-92. PubMed ID: 9210482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
    Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein.
    Pétriz J; Gottesman MM; Aran JM
    Curr Drug Deliv; 2004 Jan; 1(1):43-56. PubMed ID: 16305369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
    Ernest S; Bello-Reuss E
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2.
    Goto M; Masuda S; Saito H; Inui K
    Biochem Pharmacol; 2003 Jul; 66(1):163-70. PubMed ID: 12818377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
    Gericke B; Borsdorf S; Wienböker I; Noack A; Noack S; Löscher W
    Fluids Barriers CNS; 2021 Aug; 18(1):36. PubMed ID: 34344390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line.
    Kawamoto S; Deguchi T; Nezesa S; Yamada S; Okano M; Kawada Y
    Urol Res; 1997; 25(6):407-12. PubMed ID: 9443650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
    Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
    Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells.
    Li C; Yang W; Gai X; Zhang Y; Li Y; Fu H
    Mol Med Rep; 2012 Nov; 6(5):977-82. PubMed ID: 22961482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.